DalsnaFinance › IPOs › Vir Biotechnology Inc › IPO
Vir Biotechnology, Inc. completed its initial public offering on NASDAQ on October 11, 2019, pricing at $20.00 a share.
| Ticker | VIR |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 11, 2019 |
| Offering price | $20.00 |
| Shares offered | 7,142,858 |
| Total raised | $143M |
Vir Biotechnology, Inc. sold 7,142,858 shares at $20.00 each on NASDAQ. Multiplied out, that is $142.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $143 million total recorded for the deal.
Vir Biotechnology, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Vir Biotechnology, Inc.. This page is general information, not investment advice.